X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cytoreductive nephrectomy (376) 376
humans (311) 311
index medicus (264) 264
urology & nephrology (225) 225
oncology (194) 194
cancer (192) 192
kidney neoplasms - pathology (178) 178
renal cell carcinoma (170) 170
male (161) 161
kidney neoplasms - surgery (160) 160
survival (159) 159
carcinoma, renal cell - surgery (157) 157
interferon-alpha (151) 151
female (149) 149
metastasis (149) 149
carcinoma, renal cell (135) 135
middle aged (133) 133
nephrectomy (131) 131
aged (129) 129
targeted therapy (122) 122
carcinoma, renal cell - pathology (111) 111
immunotherapy (107) 107
care and treatment (105) 105
prognosis (105) 105
surgery (102) 102
treatment outcome (100) 100
radical nephrectomy (94) 94
sunitinib (94) 94
nephrectomy - methods (90) 90
carcinoma, renal cell - secondary (85) 85
kidney neoplasms - mortality (85) 85
kidney neoplasms - therapy (85) 85
carcinoma, renal cell - mortality (83) 83
carcinoma, renal cell - therapy (83) 83
retrospective studies (83) 83
adult (79) 79
kidney cancer (79) 79
neoplasm metastasis (79) 79
carcinoma, renal cell - drug therapy (77) 77
kidney neoplasms - drug therapy (75) 75
urology (70) 70
renal-cell carcinoma (67) 67
antineoplastic agents - therapeutic use (66) 66
combined modality therapy (59) 59
aged, 80 and over (58) 58
cytoreductive surgery (58) 58
therapy (57) 57
analysis (55) 55
carcinoma (52) 52
neoplasm staging (51) 51
prognostic-factors (49) 49
metastatic renal cell carcinoma (46) 46
health aspects (45) 45
medicine & public health (45) 45
phase-iii trial (45) 45
sorafenib (44) 44
survival analysis (43) 43
survival rate (43) 43
impact (40) 40
metastases (39) 39
mortality (37) 37
nephron-sparing surgery (37) 37
research (37) 37
patient outcomes (36) 36
metastasectomy (35) 35
risk factors (35) 35
double-blind (34) 34
randomized-trial (34) 34
tumors (32) 32
interleukin-2 (31) 31
molecular targeted therapy (31) 31
neoadjuvant therapy (31) 31
laparoscopy (28) 28
resection (28) 28
disease-free survival (26) 26
indoles - therapeutic use (26) 26
pyrroles - therapeutic use (26) 26
trial (26) 26
chemotherapy (25) 25
chemotherapy, adjuvant (25) 25
clear cell-type renal cell carcinoma (25) 25
medical prognosis (25) 25
risk assessment (25) 25
article (24) 24
endothelial growth-factor (24) 24
follow-up studies (24) 24
patient selection (24) 24
development and progression (23) 23
proportional hazards models (23) 23
systemic therapy (23) 23
time factors (23) 23
bevacizumab (22) 22
complications (22) 22
management (22) 22
prostate cancer (22) 22
abridged index medicus (21) 21
cytoreduction surgical procedures (21) 21
kidney (21) 21
medical colleges (21) 21
multivariate analysis (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (414) 414
German (21) 21
French (14) 14
Russian (5) 5
Spanish (5) 5
Turkish (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 10/2019, Volume 76, Issue 4, pp. 437 - 440
The European Organisation for Research and Treatment of Cancer SURTIME trial explored timing of sunitinib, a tyrosine kinase inhibitor (TKI), and cytoreductive... 
Renal cell carcinoma | Cytoreductive nephrectomy | Surgical safety | Clinical trials | Analysis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 5, pp. 417 - 427
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 4, pp. 704 - 710
Journal Article
Journal Article
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 67, Issue 5, pp. 913 - 924
Journal Article